Belpointe Asset Management’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CPUH.WS
LP
SRCM
PIF
JRCM
PAMP
AC
ETH
SCM
TP
Belpointe Asset Management's CPUH.WS Position: Q1 2023 in Review
Belpointe Asset Management sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q1 2023, closing a stake of 1,163 shares — an estimated $131 sold.
Belpointe Asset Management first reported a position in CPUH.WS in Q4 2022 and held it in 1 quarter. The position peaked at $131 in Q4 2022. 61 funds tracked by Wall St. Rank hold CPUH.WS as of Q1 2023.
- Belpointe Asset Management reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
- Belpointe Asset Management sold 1,163 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q1 2023, an estimated $131.
- Belpointe Asset Management first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q4 2022 and held it in 1 quarter.
- Belpointe Asset Management's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $131 in Q4 2022.
- 61 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q1 2023.
Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.